DNAA

DNAA

Social Capital Suvretta Holdings Corp. I

Print
SPAC Target Focus
Healthcare & Medical
Expected Close Date
June 30, 2023
IPO Date
2021-06-30
IPO Size(M)
$ 250M
Underwriters
Morgan Stanley

Management

Chamath Palihapitiya (Managing Partner of Social Capital, Chairman of Virgin Galactic), Vladimir Coric (CEO of Biohaven Pharmaceuticals)

Management Team / Advisory Board Bios

Chamath Palihapitiya (Managing Partner of Social Capital, Chairman of Virgin Galactic), Vladimir Coric (CEO of Biohaven Pharmaceuticals)
Amount Raised : $0
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter

0 Comments